Skip to Content

Join the 'Zelnorm' group to help and get support from people like you.

Zelnorm News

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

Posted 30 Mar 2007 by Drugs.com

[Posted 03/30/2007] FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years of age with chronic constipation. FDA analysis of safety data pooled from 29 clinical trials involving over 18,000 patients showed an excess number of serious cardiovascular adverse events, including angina, heart attacks, and stroke, in patients taking Zelnorm compared to patients given placebo. Patients taking Zelnorm should contact their healthcare professional to discuss treatment alternatives and seek emergency medical care if they experience severe chest pain, shortness of breath, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke. Healthcare professionals should ... Read more

Related support groups: Irritable Bowel Syndrome, Zelnorm

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

Posted 28 Apr 2004 by Drugs.com

The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation. This new information relates to a Warning for serious consequences of diarrhea and a Precaution for rare reports of ischemic colitis in post marketing use of Zelnorm.[April 26, 2004 Letter - Novartis][April 2004 Revised Label - Novartis][April 28, 2004 Drug Information Page - FDA] Read more

Related support groups: Irritable Bowel Syndrome, Zelnorm

Ask a Question

Further Information

Related Condition Support Groups

Irritable Bowel Syndrome, Constipation - Chronic

Zelnorm Patient Information at Drugs.com